Cargando…
Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?
MYH9 was first discovered due to thrombocytopenia caused by MYH9 mutation-related abnormalities. In recent years, researchers have increasingly found that MYH9 plays an important role in cancer as a cytokine involved in cytoskeletal reorganization, cellular pseudopodia formation, and migration. MYH9...
Autores principales: | Wang, Yunmei, Liu, Shuguang, Zhang, Yanjun, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366299/ https://www.ncbi.nlm.nih.gov/pubmed/30739906 http://dx.doi.org/10.12659/MSM.912320 |
Ejemplares similares
-
Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia
por: Thurlapati, Aswani, et al.
Publicado: (2021) -
Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017) -
Myosin heavy chain is stabilized by BCL-2 interacting cell death suppressor (BIS) in skeletal muscle
por: Hong, Jin, et al.
Publicado: (2016) -
Tumor-Suppressor Genes and Oncogenes
Publicado: (1993) -
Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)